Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lipocine Inc LPCN

Healthcare
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development candidates include: LPCN 1154, oral brexanolone, for treatment of postpartum depression, LPCN 2101 for epilepsy, LPCN 2203 for essential tremor... see more

Recent & Breaking News (NDAQ:LPCN)

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lipocine Inc. - LPCN

GlobeNewswire August 2, 2016

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Lawsuit Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016

Business Wire August 1, 2016

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lipocine, Inc. (LPCN) And Reminds Investors with Losses to Contact the Firm

GlobeNewswire July 29, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline – LPCN

GlobeNewswire July 29, 2016

August 30th Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of Deadline in the Class Action Lawsuit Against Lipocine Inc.

Business Wire July 29, 2016

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit – LPCN

GlobeNewswire July 28, 2016

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. and Encourages Investors With Losses to Contact the Firm

Business Wire July 26, 2016

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN

GlobeNewswire July 26, 2016

Lawsuit for Investors in shares of Lipocine Inc (NASDAQ:LPCN) announced by Shareholders Foundation

GlobeNewswire July 25, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors in Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 – LPCN

GlobeNewswire July 22, 2016

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Lipocine, Inc.

Business Wire July 21, 2016

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Lipocine Inc. Investors and Encourages Investors to Contact the Firm

Business Wire July 21, 2016

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire July 19, 2016

SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lipocine Inc. Investors of Important Deadline in Class Action Filed by Firm - LPCN

Business Wire July 18, 2016

INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire July 18, 2016

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lipocine, Inc. (LPCN)

GlobeNewswire July 11, 2016

IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Lipocine Inc. and Reminds Investors With Losses to Contact the Firm

Business Wire July 9, 2016

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN

GlobeNewswire July 8, 2016

IMPORTANT NOTICE TO SHAREHOLDERS:  Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Dead

GlobeNewswire July 7, 2016

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

Business Wire July 7, 2016